Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Current Leases (2023 - 2025)

Beta Bionics' Current Leases history spans 3 years, with the latest figure at $1.9 million for Q4 2025.

  • For Q4 2025, Current Leases rose 26.75% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $1.9 million, up 26.75%, while the annual FY2025 figure was $1.9 million, 26.75% up from the prior year.
  • Current Leases for Q4 2025 was $1.9 million at Beta Bionics, down from $2.0 million in the prior quarter.
  • Across five years, Current Leases topped out at $2.0 million in Q3 2025 and bottomed at $1.2 million in Q4 2023.
  • The 3-year median for Current Leases is $1.5 million (2024), against an average of $1.6 million.
  • The largest annual shift saw Current Leases rose 24.92% in 2024 before it increased 26.75% in 2025.
  • A 3-year view of Current Leases shows it stood at $1.2 million in 2023, then grew by 24.92% to $1.5 million in 2024, then rose by 26.75% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for BBNX's Current Leases are $1.9 million (Q4 2025), $2.0 million (Q3 2025), and $1.5 million (Q2 2025).